Overview

Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies

Status:
Not yet recruiting
Trial end date:
2023-07-24
Target enrollment:
Participant gender:
Summary
This study is a single-arm, open-label, multi-centre drug-drug interaction (DDI) study of AZD5305 administered orally in patients with advanced solid tumours.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Itraconazole